Similarly, conditional Bach2 or Senp3 ablation in Treg cells leads to enhanced anti-tumor immunity and delayed progression of transplanted colon cancer and melanoma, respectively, demonstrating a Treg-cell-intrinsic function of Bach2 in cancer [73,75]. This evidence concerns the gene BACH2 and malignant colon neoplasm.